This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Baylor College of Medicine. Active years: 2013-2016.
Company Filing History:
Years Active: 2013-2016
Title: Erol Bakkalbasi: Innovator in Gene Therapy
Introduction
Erol Bakkalbasi is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of gene therapy, holding a total of 3 patents. His work focuses on innovative nucleic acid molecule compositions that have the potential to revolutionize gene therapy applications.
Latest Patents
Bakkalbasi's latest patents include "Supercoiled minicircle DNA for gene therapy applications" and "Supercoiled minivectors for gene therapy applications." The first patent relates to nucleic acid molecule compositions comprising minivectors encoding a nucleic acid sequence and methods of gene therapy using these minivectors. The second patent also focuses on nucleic acid molecule compositions, specifically MiniVectors™ encoding a nucleic acid sequence and their application in gene therapy.
Career Highlights
Erol Bakkalbasi is affiliated with Baylor College of Medicine, where he continues to advance research in gene therapy. His innovative approaches have garnered attention in the scientific community, contributing to the understanding and application of gene therapy techniques.
Collaborations
Bakkalbasi has collaborated with notable colleagues, including E Lynn Zechiedrich and Jonathan Fogg. These partnerships have enhanced his research and expanded the impact of his inventions in the field.
Conclusion
Erol Bakkalbasi is a key figure in the advancement of gene therapy, with a focus on innovative nucleic acid compositions. His contributions through patents and collaborations continue to shape the future of medical science.